Cancer survivors are at greater risk of developing another cancer and dying from it, a new study finds.
These new cancers can result from a genetic predisposition, from treatments such as radiation and chemotherapy used to fight the first cancer, as well as from unhealthy lifestyles such as smoking and obesity, according to researchers from the American Cancer Society.
As the Affordable Care Act faces scrutiny once more from the U.S. Supreme Court, new research shows it may be helping to save American lives otherwise lost to cancer.
The study found that expansions of health insurance coverage through Medicaid — a feature of Obamacare — appeared tied to a rise in the number of cancers spotted via screening when they were still early in development. C...
Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds.
Researchers found that of more than 1.6 million young Swedish women, those who'd gotten the HPV vaccine were about two-thirds less likely to be diagnosed with cervical cancer than their unvaccinated peers.
A single dose of the human papillomavirus (HPV) vaccine works as well as multiple doses to protect older teen girls against preinvasive cervical disease, which can develop into cervical cancer, researchers say.
For the study, the researchers analyzed data on more than 133,000 females aged 9 to 26. Half weren't vaccinated and half received one or more HPV vaccine doses between January...
Vaccination and screening could nearly wipe out cervical cancer in North America in the next 20 years and rid the world of the disease within the next century, researchers say.
In a new study, the researchers assessed the potential impacts of the World Health Organization's (WHO) draft strategy for cervical cancer elimination, which calls for 90% of girls to be vaccinated against ...
A 29% drop in U.S. cancer deaths between 1991 and 2017 was driven by declines in deaths from four major cancers -- lung, colon, breast and prostate, according to the latest American Cancer Society (ACS) annual report.
Cancer deaths in the United States fell 2.2% between 2016 and 2017, the largest-ever single-year decrease.
Many American teen girls and young women under the age of 21 are undergoing pelvic exams and Pap tests they just don't need, a new study finds.
"Parents of adolescents and young women should be aware that cervical cancer screening is not recommended routinely in this age group," said study senior researcher Dr. George Sawaya. He is professor of obstetrics, gynecology and reproductiv...
In a finding that might make the HPV vaccine more palatable to many, new research suggests a single dose may provide just as much protection from cervical cancer as the recommended two to three doses do.
"The vaccine is extremely effective, and can prevent over 90% of nearly 35,000 cancers caused by HPV every year among men and women," explained study author Ashish Deshmukh. He's ...
While there's been a slight uptick in the number of American boys who get the HPV vaccine to help prevent certain cancers, a new study finds there's been almost no increase for girls.
And overall, too few kids are getting the human papillomavirus (HPV) vaccine (Gardasil, Cervarix), which can help provide them with a lifetime of protection against cancers of the cervix, genitals, mouth...
Young women are far less likely now to get an annual pelvic exam than they were in decades past, a new report finds.
In 1988, about 42% of those aged 15 to 20 got the standard gynecologic exam, but by 2017 that number had dropped by half, to just under 22%, according to researchers from the U.S. Centers for Disease Control and Prevention.
A type of cervical cancer that's less sensitive to Pap testing is increasing among white women in the United States, new research shows.
An overall decline in cervical cancer rates in recent decades has been driven by decreases in squamous cell carcinomas. Most of the rest of cervical cancer cases are adenocarcinomas, which are less likely to be detected by Pap testing and are mainly ...
The human papillomavirus (HPV) vaccine is largely responsible for a decline in precancerous cervical lesions among young women in the United States, a new government report shows.
The number of these precancerous lesions detected during screening went down from an estimated 216,000 cases in 2008 to 196,000 cases in 2016, researchers from the U.S. Centers for Disease Control and Preven...
HPV vaccination rates for younger American adolescents are alarmingly low, researchers say.
"While we have seen gains in HPV vaccination coverage, we are still falling behind at the younger ages," said study lead author Robert Bednarczyk. He'sassistant professor of global health and epidemiology at Emory University in Atlanta.
Human papillomavirus (HPV) is a sexually transmi...
About 4,000 women in the United States die from cervical cancer each year -- even though there's a preventive vaccine and screening to catch the disease early.
"When cervical cancer is found early, it is highly treatable," said Dr. Sarah Ramirez, a family medicine physician with Penn State Health. "So it's important to make sure you are being screened for this disease."
HPV vaccination rates are still too low to cut cervical cancer cases as much as is possible in the United States, a new report warns.
While HPV (human papillomavirus) vaccination has increased in recent years, rates remain well below the federal government's Healthy People 2020 goal of 80 percent of age-eligible adolescents, according to the recent report.
Testing for human papillomavirus (HPV) has become the standard of care in screening for cervical cancer. But now, Canadian researchers say it may become unnecessary in women aged 55 or older who have one negative result with the test.
The DNA-based HPV test is highly accurate in detecting 14 high-risk strains of the virus that causes the majority of cervical cancers.
HPV vaccination rates continue to climb in the United States, jumping a full 5 percentage points between 2016 and 2017, a new government report shows.
Nearly 66 percent of boys and girls aged 13 to 17 received the first dose in the vaccine series in 2017, according to the U.S. Centers for Disease Control and Prevention researchers. Further, nearly 49 percent of adolescents received al...